Department of Surgery, Uniformed Services University of the Health Sciences and Walter Reed National Military Medical Center, Bethesda, Maryland.
Department of Surgery, Uniformed Services University of the Health Sciences and Walter Reed National Military Medical Center, Bethesda, Maryland.
J Surg Res. 2020 Dec;256:171-179. doi: 10.1016/j.jss.2020.06.042. Epub 2020 Jul 21.
Resuscitative endovascular balloon occlusion of the aorta (REBOA) reduces blood loss and improves hemodynamics. Complete occlusion results in distal ischemia, limiting its use for prolonged care. This study evaluated two next-generation partial REBOA (pREBOA) catheters and their ability to achieve targeted distal aortic flow.
Swine underwent hemorrhagic shock, complete aortic occlusion, controlled continuous balloon deflation, and targeted distal perfusion (TDP; 300-mL/min) phases. They were randomized into three groups (n = 6/group), one managed with the current ER-REBOA (ER), and two with the new pREBOA technologies: a bilobed (BL) device and a semicompliant pREBOA-PRO (PRP). Hemodynamics including flow rates and mean arterial pressures at the carotid artery and infrarenal aorta were recorded.
Hemodynamics were comparable between groups during hemorrhage and complete occlusion phases. During the controlled continuous balloon deflation phase, the distal aortic flow rate strongly correlated with percent balloon volume in BL and PRP groups, suggesting a precise control of distal perfusion. The slope of flow-balloon-volume curves was greater in the ER group than BL and PRP groups, indicating the change in distal aortic flow rate was more sensitive to the balloon volume (less titratable) when using ER. During the TDP phase, variation in distal aortic flow and mean arterial pressure with respect to the target flow was lower in ER and PRP groups, than the BL group.
Pressure-regulated occlusion using the next-generation pREBOA catheters is more controlled than the first-generation ER-REBOA catheter and allow for targeted and precise distal perfusion.
主动脉球囊阻断复苏术(REBOA)可减少出血量并改善血液动力学。完全阻断会导致远端缺血,限制了其在长时间治疗中的应用。本研究评估了两种下一代部分 REBOA(pREBOA)导管及其实现目标性远端主动脉血流的能力。
猪经历失血性休克、完全主动脉阻断、控制性连续球囊放气和目标性远端灌注(TDP;300 毫升/分钟)阶段。它们随机分为三组(每组 n=6),一组采用当前的 ER-REBOA(ER),两组采用新的 pREBOA 技术:双叶(BL)装置和半顺应性 pREBOA-PRO(PRP)。记录颈动脉和肾下腹主动脉的血流率和平均动脉压等血液动力学参数。
在出血和完全阻断阶段,各组的血液动力学参数相似。在控制性连续球囊放气阶段,BL 和 PRP 组的远端主动脉血流率与球囊体积的百分比密切相关,表明远端灌注得到了精确控制。ER 组的流量-球囊体积曲线斜率大于 BL 和 PRP 组,表明 ER 时远端主动脉血流率的变化对球囊体积(更难调节)更敏感。在 TDP 阶段,ER 和 PRP 组的远端主动脉血流和平均动脉压相对于目标血流的变化较小,而 BL 组则较大。
使用下一代 pREBOA 导管进行压力调节阻断比第一代 ER-REBOA 导管更可控,可实现目标性和精确性的远端灌注。